Recently, sandwich-cultured (SC) rat hepatocytes have been used as an in vi
tro model to assess biliary excretion of drugs and xenobiotics. The purpose
of the present study was to validate the use of SC rat hepatocytes for the
in vitro assessment of P-glycoprotein (P-gp)-mediated biliary drug excreti
on. The specific and fluorescent P-gp substrate rhodamine 123 (Rh123) and t
he P-gp substrate digoxin were selected as model compounds. Rh123 and digox
in accumulation and Rh123 efflux under standard and Ca2+-free conditions we
re quantified in SC rat hepatocytes to determine substrate secretion into c
analicular networks in vitro. The major role of P-gp in the biliary excreti
on of these compounds was confirmed by inhibition experiments with the pote
nt P-gp inhibitor GF120918. Hepatocyte culture conditions, including media
type and time in culture, significantly affected Rh123 biliary excretion. P
-gp expression, as assessed by Western blot, was increased with culture tim
e. Dexamethasone (an in vivo inducer of P-gp) concentrations ranging from 0
.01 to 1 muM in the cell culture medium did not influence P-gp expression o
r Rh123 biliary excretion. Rh123 and digoxin biliary clearance values, pred
icted from SC rat hepatocyte data, were consistent with values reported in
vivo and in isolated perfused rat liver studies. In conclusion, the results
of this study demonstrate the utility of SC rat hepatocytes as an in vitro
model to study and predict the biliary excretion of P-gp substrates.